Clinical Cardiology Alert – September 1, 2004
September 1, 2004
View Issues
-
Stem Cells: Post-Myocardial Infarction
Autologous bone marrow stem cells injected into the infarct-related artery, after successful PCI, improves LVEF at 6 months, compared to controls. -
Prognosis of Women with Syndrome X
An abnormal stress MRS, indicative of myocardial ischemia in symptomatic women without CAD, predicts cardiovascular events, especially hospitalization for unstable angina. -
Abdominal Aortic Aneurysm
Annual, or less frequent, surveillance intervals are effective for aneurysms < 45 mm in diameter. -
Cryoablation of Supraventricular Tachycardia
Cryoablation offers an alternative approach to radiofrequency ablation. -
Long-Term Comparison of ICD vs Amiodarone
The benefit of ICD therapy, compared to amiodarone therapy in patients with life-threatening arrhythmia, continues to increase over time, and long-term data support the use of an ICD as first line therapy for secondary prevention of sudden cardiac death. -
Q-Wave or Non-Q-Wave Myocardial Infarction: Does It Make Any Difference?
The Q-wave/non-Q-wave distinction is useful clinically, and the primary determinant of the presence of Q-waves is the total size of the underlying infarction, rather than its transmural extent. -
Pharmacology Watch: New Clinical Guidelines on Cholesterol Management
The National Cholesterol Education Program (NCEP), a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management. -
Clinical Briefs in Primary Care Supplement